Compare CYTK & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | TX |
|---|---|---|
| Founded | 1997 | 1961 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.3B |
| IPO Year | 2004 | 2006 |
| Metric | CYTK | TX |
|---|---|---|
| Price | $63.34 | $41.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 6 |
| Target Price | ★ $84.81 | $37.08 |
| AVG Volume (30 Days) | ★ 1.8M | 217.4K |
| Earning Date | 02-26-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 6.45% |
| EPS Growth | N/A | ★ 635.85 |
| EPS | N/A | ★ 2.97 |
| Revenue | $87,211,000.00 | ★ $15,710,564,000.00 |
| Revenue This Year | $341.94 | N/A |
| Revenue Next Year | $75.44 | $7.22 |
| P/E Ratio | ★ N/A | $14.07 |
| Revenue Growth | ★ 2609.26 | N/A |
| 52 Week Low | $29.31 | $24.00 |
| 52 Week High | $70.98 | $44.16 |
| Indicator | CYTK | TX |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 54.42 |
| Support Level | $62.13 | $42.22 |
| Resistance Level | $65.88 | $44.16 |
| Average True Range (ATR) | 2.59 | 1.03 |
| MACD | 0.07 | -0.06 |
| Stochastic Oscillator | 54.84 | 46.12 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.